Director, Cutaneous Clinical and Translational Research
Moffitt Cancer Center
Tampa, Florida, United States
Dr. Tarhini is a Senior Member and Director of Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute. Dr Tarhini obtained a Bachelor of Science from the American University of Beirut then moved to Europe for his MD from the Lithuanian University of Health Sciences. He completed Internal Medicine Residency and Hematology-Oncology Fellowship at University of Pittsburgh Medical Center. In parallel, and as he joined the faculty of the University of Pittsburgh, he completed Master of Science in Clinical Research and PhD in Clinical and Translational Science from University of Pittsburgh School of Medicine. At University of Pittsburgh he was promoted from the rank of Assistant Professor to Associate Professor and eventually achieved tenure in the Department of Medicine. Dr. Tarhini then joined the Cleveland Clinic as Director, Melanoma and Skin Cancer Program and Director, Center for Immuno-Oncology Research. He was also appointed as Professor of Medicine at Case Western Reserve University. Dr Tarhini has led multiple novel investigator-initiated clinical and translational studies, national US Cooperative Group studies and NIH-funded translational projects including within the University of Pittsburgh’s Skin Spore Grant where he has served for 10 years as Project Co-leader of the Biomarker Skin Spore Project. He served as principal investigator of the ETCTN grant at Case Comprehensive Cancer Center. He currently serves as a chair/co-chair on several cooperative group trials, including E1609, S1404, EA6141, E3612, E3611, NCI8628, NCI10061 and EA6194. He was presented the 2009 University of Pittsburgh Cancer Institute Junior Scholar Award in Clinical Research and the 2010 Eastern Cooperative Oncology Group (ECOG) Young Investigator Award. He recently served as a Track Leader of ASCO’s Cancer Education Committee Melanoma/Skin Cancers Track and a member of the Scientific Committee. He also served as Organizer of the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting.
Thursday, March 5, 2026
3:07 PM - 3:14 PM MST